Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia.

Congenital myasthenic syndrome due to homozygous CHRNE mutations: report of patients in Arabia.

We describe the clinical characteristics of 3 siblings from 1 family with congenital myasthenic syndrome due to homozygous mutations of the gene coding for the epsilon subunit of the acetylcholine receptor (CHRNE). Onset of symptoms occurred in the first few months of life with ptosis, restricted oc...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Salih, M, Oystreck, D, Al-Faky, Y, Kabiraj, M, Omer, M, Subahi, E, Beeson, D, Abu-Amero, K, Bosley, T
Format:	Journal article
Język:	English
Wydane:	2011

Podobne zapisy

<italic>De Novo</italic> CHRNE Mutation: Congenital Myasthenic Syndrome
od: Hande Gazeteci Tekin, i wsp.
Wydane: (2019-12-01)

Homozygous Duplication in the <i>CHRNE</i> in a Family with Congenital Myasthenic Syndrome 4C: 18-Year Follow Up
od: Ahmad M. Almatrafi, i wsp.
Wydane: (2023-11-01)

Divergent Phenotypes with Same CHRNE Mutation in Two Siblings with Congenital Myasthenic Syndrome
od: Ankith Naveen, i wsp.
Wydane: (2024-05-01)

Blood biomarker fingerprints in a cohort of patients with CHRNE-related congenital myasthenic syndrome
od: Adela Della Marina, i wsp.
Wydane: (2025-02-01)

CHRNE Mutation and Congenital Myasthenia
od: J Gordon Millichap
Wydane: (2009-01-01)

P397: A case of congenital myasthenic syndrome with AChR deficiency due to biallelic variants in CHRNE gene
od: Aashish Batheja, i wsp.
Wydane: (2024-01-01)

A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report
od: Chang, T, i wsp.
Wydane: (2016)

The congenital myasthenic syndromes.
od: Palace, J, i wsp.
Wydane: (2008)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
od: Lashley, D, i wsp.
Wydane: (2010)

Congenital myasthenic syndromes.
od: Beeson, D, i wsp.
Wydane: (1997)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
od: Cossins, J, i wsp.
Wydane: (2013)

Congenital myasthenic syndrome patients due to AChR epsilon subunit mutations
od: Bonifati, D, i wsp.
Wydane: (2004)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
od: Cossins, J, i wsp.
Wydane: (2013)

Synaptic dysfunction in congenital myasthenic syndromes.
od: Beeson, D
Wydane: (2012)

Congenital myasthenic syndromes: recent advances
od: Beeson, D
Wydane: (2016)

Congenital myasthenic syndromes: an update.
od: Finlayson, S, i wsp.
Wydane: (2013)

Therapeutic strategies for congenital myasthenic syndromes
od: Lee, M, i wsp.
Wydane: (2018)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
od: Mewasingh, L, i wsp.
Wydane: (2006)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
od: Finlayson, S, i wsp.
Wydane: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
od: Finlayson, S, i wsp.
Wydane: (2013)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
od: Beeson, D
Wydane: (2008)

Congenital myasthenic syndromes and the neuromuscular junction.
od: Cruz, P, i wsp.
Wydane: (2014)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
od: Burke, G, i wsp.
Wydane: (2013)

Congenital myasthenic syndrome caused by mutations in DPAGT.
od: Klein, A, i wsp.
Wydane: (2015)

Congenital myasthenic syndrome with episodic apnoea: new mutations and an unusual complication
od: Davies, N, i wsp.
Wydane: (2004)

A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance
od: Webster, R, i wsp.
Wydane: (2012)

A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance.
od: Webster, R, i wsp.
Wydane: (2012)

Arthrogryposis multiplex congenita associated with congenital myasthenic syndrome due to mutations in the acetylcholine receptor delta subunit
od: Brownlow, S, i wsp.
Wydane: (2000)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
od: Rodríguez Cruz, P, i wsp.
Wydane: (2018)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
od: Lashley, D, i wsp.
Wydane: (2009)

Congenital myasthenic syndromes: Report of 7 Chile
od: Kleinsteuber, K, i wsp.
Wydane: (2003)

New diagnosis in Chilean population: congenital myasthenic syndromes
od: Kleinsteuber, K, i wsp.
Wydane: (2005)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
od: Spillane, J, i wsp.
Wydane: (2012)

Clinical features in a large Iranian family with a limb-girdle congenital myasthenic syndrome due to a mutation in DPAGT1.
od: Basiri, K, i wsp.
Wydane: (2013)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
od: Man, S, i wsp.
Wydane: (2005)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
od: Beeson, D, i wsp.
Wydane: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
od: Beeson, D, i wsp.
Wydane: (2008)

Development of a dHPLC-WAVE service to detect mutations in congenital myasthenic syndrome
od: Man, S, i wsp.
Wydane: (2002)

The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies
od: Vanhaesebrouck, AE, i wsp.
Wydane: (2019)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
od: Yamanashi, Y, i wsp.
Wydane: (2008)